Neeraj Upmanyu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Neeraj Upmanyu has a total of 151 co-authors. Here are the top co-authors by number of shared publications:
- Kamal Shah
Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India
8 shared publications Pradeep Mishra
Institute of Pharmaceutical Research, GLA University, Mathura, U.P.- 281406, India
6 shared publications- Jeetendra Kumar Gupta
Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India
3 shared publications Sharad Prakash Pandey
3 shared publicationsTripti Shukla
3 shared publicationsAmol Chandekar
Pharmacognosy and Phytochemistry Divison, R.K.D.F. College of Pharmacy, Bhopal, India; Peoples Institute of Pharmacy & Research Centre, Bhopal, India
2 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 38 (11) , 2938-2946
Design, Synthesis, Biological Evaluation, Molecular Docking, Pharmacophore Modelling and 3D-QSAR Analysis of Novel Substituted Imidazolidine Derivatives as Potential Antimicrobial Agents
The present study reports the combined experimental and computational approaches to investigate the antimicrobial potential of 104 structurally diverse substituted imidazolidine derivatives. Selected compounds were synthesized based on their docking results and characterized by IR, 1H NMR and 13C NMR spectroscopy and mass spectrometry. Their antimicrobial activity was assessed in vitro against selected bacterial and fungal strains. Among the tested compounds, derivatives 47 and 52 exhibited the strongest activity, with compound 47 showing antibacterial activity comparable to that of amoxicillin. Molecular docking studies against lanosterol 14α-demethylase (CYP51; PDB ID: 1E9X) were performed to explore the possible interactions of the compounds within the enzyme-binding pocket. Compounds 47 and 52 achieved docking scores of -10.4 and -10.3 kcal/mol, respectively, while compounds 15, 18 and 21 each recorded a score of -10.2 kcal/mol. The docked complexes exhibited hydrogen bonding, π-π stacking, π-cation, π-alkyl and hydrophobic interactions. Pharmacophore modelling identified one hydrogen-bond acceptor feature, one hydrophobic feature and three aromatic-ring features associated with the activity profile. The optimized three-dimensional quantitative structure–activity relationship (3D-QSAR) model yielded an (R2) value of 0.6682, a (Q2) value of 0.3463, a Pearson correlation coefficient of 0.7497 and a stability value of 0.847. Analysis of the steric, electrostatic and hydrophobic contour maps provided further insight into the influence of substituent identity and spatial arrangement on antimicrobial activity. The experimental findings identify compounds 47 and 52 as promising candidates for further optimization of imidazolidine-based antimicrobial agents.
- 13 November 2026
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 38 (11) , 2938-2946
Open AccessDesign, Synthesis, Biological Evaluation, Molecular Docking, Pharmacophore Modelling and 3D-QSAR Analysis of Novel Substituted Imidazolidine Derivatives as Potential Antimicrobial Agents
The present study reports the combined experimental and computational approaches to investigate the antimicrobial potential of 104 structurally diverse substituted imidazolidine derivatives. Selected compounds were synthesized based on their docking results and characterized by IR, 1H NMR and 13C NMR spectroscopy and mass spectrometry. Their antimicrobial activity was assessed in vitro against selected bacterial and fungal strains. Among the tested compounds, derivatives 47 and 52 exhibited the strongest activity, with compound 47 showing antibacterial activity comparable to that of amoxicillin. Molecular docking studies against lanosterol 14α-demethylase (CYP51; PDB ID: 1E9X) were performed to explore the possible interactions of the compounds within the enzyme-binding pocket. Compounds 47 and 52 achieved docking scores of -10.4 and -10.3 kcal/mol, respectively, while compounds 15, 18 and 21 each recorded a score of -10.2 kcal/mol. The docked complexes exhibited hydrogen bonding, π-π stacking, π-cation, π-alkyl and hydrophobic interactions. Pharmacophore modelling identified one hydrogen-bond acceptor feature, one hydrophobic feature and three aromatic-ring features associated with the activity profile. The optimized three-dimensional quantitative structure–activity relationship (3D-QSAR) model yielded an (R2) value of 0.6682, a (Q2) value of 0.3463, a Pearson correlation coefficient of 0.7497 and a stability value of 0.847. Analysis of the steric, electrostatic and hydrophobic contour maps provided further insight into the influence of substituent identity and spatial arrangement on antimicrobial activity. The experimental findings identify compounds 47 and 52 as promising candidates for further optimization of imidazolidine-based antimicrobial agents.
- Open Access
- 4 August 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (30) , e74007
Recent Updates on Novel Quinazoline‐Hybrid Molecules Possessing EGFR‐Mediated Anticancer Activity
As the first member of the receptor tyrosine kinase family, epidermal growth factor (EGFR) has been linked to human cancers through numerous lines of evidence. Research on EGFR has also led to the development of several key theories regarding cancer progression. Through a vast array of paracrine loops, each of which regulates a crucial stage in the metastasis cascade, EGFR not only maintains cell proliferation but also confers resistance to anti‐cancer cytotoxic treatments. To identify EGFR tyrosine kinase inhibitors (TKIs), simulation studies have been used to produce several small molecules, especially those containing quinazolines. The design process also evaluated the emergence of resistance problems and epigenetic changes, which eventually reduced drug efficacy and made it clear that more study in this field was required. The genetic changes taking place in the EGFR tyrosine kinase domain have been thoroughly studied in recent decades. These changes have made it possible to create highly effective inhibitors. The structure–activity relationship (SAR) and cytotoxic activity of several quinazoline derivatives with demonstrated EGFR‐inhibitory antiproliferative activity are highlighted in this review. In the present paper, we report the EGFR‐mediated anticancer potential of quinazoline derivatives discovered after 2020.
- 4 August 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (30) , e74007
Open AccessRecent Updates on Novel Quinazoline‐Hybrid Molecules Possessing EGFR‐Mediated Anticancer Activity
As the first member of the receptor tyrosine kinase family, epidermal growth factor (EGFR) has been linked to human cancers through numerous lines of evidence. Research on EGFR has also led to the development of several key theories regarding cancer progression. Through a vast array of paracrine loops, each of which regulates a crucial stage in the metastasis cascade, EGFR not only maintains cell proliferation but also confers resistance to anti‐cancer cytotoxic treatments. To identify EGFR tyrosine kinase inhibitors (TKIs), simulation studies have been used to produce several small molecules, especially those containing quinazolines. The design process also evaluated the emergence of resistance problems and epigenetic changes, which eventually reduced drug efficacy and made it clear that more study in this field was required. The genetic changes taking place in the EGFR tyrosine kinase domain have been thoroughly studied in recent decades. These changes have made it possible to create highly effective inhibitors. The structure–activity relationship (SAR) and cytotoxic activity of several quinazoline derivatives with demonstrated EGFR‐inhibitory antiproliferative activity are highlighted in this review. In the present paper, we report the EGFR‐mediated anticancer potential of quinazoline derivatives discovered after 2020.
- 1 September 2025
- Published by Springer Nature
- p. 43-75
Materials for Fused Deposition Modelling (FDM) 3D Printing Technology
- 1 September 2025
- Published by Springer Nature
- p. 43-75
Materials for Fused Deposition Modelling (FDM) 3D Printing Technology
- 23 February 2024
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 113 (7) , 1919-1926
Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations
- 23 February 2024
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 113 (7) , 1919-1926
Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations
- Open Access
- 15 November 2021
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 11 (6) , 26-30
Formulation and optimization of water soluble granules of Withania Somnifera
Herbal medicines have great demand in the treatment of various kinds of illness. Ayurvedic system of medicine has consisted of many herbal sources in which ashwagandha one of them which are the very popular herbal sources. Many literature surveys suggest that ashwagandha is used as an immunomodulator, tranquilizer, antioxidant, antidiabetic, and nootropic activity. Present research work explored the potential benefit of ashwagandha by designing suitable granules of its water extract. Further, it is characterized by various parameters and In-vitro drug release Keywords: Immunomodulator, Tranquilizers Ayurvedic, Ashwagandha, Granules
- 15 November 2021
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 11 (6) , 26-30
Open AccessFormulation and optimization of water soluble granules of Withania Somnifera
Herbal medicines have great demand in the treatment of various kinds of illness. Ayurvedic system of medicine has consisted of many herbal sources in which ashwagandha one of them which are the very popular herbal sources. Many literature surveys suggest that ashwagandha is used as an immunomodulator, tranquilizer, antioxidant, antidiabetic, and nootropic activity. Present research work explored the potential benefit of ashwagandha by designing suitable granules of its water extract. Further, it is characterized by various parameters and In-vitro drug release Keywords: Immunomodulator, Tranquilizers Ayurvedic, Ashwagandha, Granules
- Open Access
- 15 September 2021
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 134 (18)
PLP2 drives collective cell migration via ZO-1-mediated cytoskeletal remodeling at the leading edge in human colorectal cancer cells
Collective cell migration (CCM), in which cell–cell integrity remains preserved during movement, plays an important role in the progression of cancer. However, studies describing CCM in cancer progression are majorly focused on the effects of extracellular tissue components on moving cell plasticity. The molecular and cellular mechanisms of CCM during cancer progression remain poorly explored. Here, we report that proteolipid protein 2 (PLP2), a colonic epithelium-enriched transmembrane protein, plays a vital role in the CCM of invasive human colorectal cancer (CRC) epithelium by modulating leading-edge cell dynamics in 2D. The extracellular pool of PLP2, secreted via exosomes, was also found to contribute to the event. During CCM, the protein was found to exist in association with ZO-1 (also known as TJP1) and to be involved in the positioning of the latter at the migrating edge. PLP2-mediated positioning of ZO-1 at the leading edge further alters actin cytoskeletal organization that involves Rac1 activation. Taken together, our findings demonstrate that PLP2, via its association with ZO-1, drives CCM in CRC epithelium by modulating the leading-edge actin cytoskeleton, thereby opening up new avenues of cancer research. This article has an associated First Person interview with the first author of the paper.
- 15 September 2021
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 134 (18)
Open AccessPLP2 drives collective cell migration via ZO-1-mediated cytoskeletal remodeling at the leading edge in human colorectal cancer cells
Collective cell migration (CCM), in which cell–cell integrity remains preserved during movement, plays an important role in the progression of cancer. However, studies describing CCM in cancer progression are majorly focused on the effects of extracellular tissue components on moving cell plasticity. The molecular and cellular mechanisms of CCM during cancer progression remain poorly explored. Here, we report that proteolipid protein 2 (PLP2), a colonic epithelium-enriched transmembrane protein, plays a vital role in the CCM of invasive human colorectal cancer (CRC) epithelium by modulating leading-edge cell dynamics in 2D. The extracellular pool of PLP2, secreted via exosomes, was also found to contribute to the event. During CCM, the protein was found to exist in association with ZO-1 (also known as TJP1) and to be involved in the positioning of the latter at the migrating edge. PLP2-mediated positioning of ZO-1 at the leading edge further alters actin cytoskeletal organization that involves Rac1 activation. Taken together, our findings demonstrate that PLP2, via its association with ZO-1, drives CCM in CRC epithelium by modulating the leading-edge actin cytoskeleton, thereby opening up new avenues of cancer research. This article has an associated First Person interview with the first author of the paper.
- Open Access
- 26 June 2021
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 33 (7) , 1692-1698
Bioanalytical Method Development and Validation for Determination of Sulfasalazine in Rabbit Plasma by HPLC-UV
In present study, an advanced, simple and a rapid reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the quantitative determination of sulfasalazine in rabbit plasma. Sulfasalazine was separated using Chromatopak C-18 basic peerless (250 mm × 4.6 mm, 5μ) column in an isocratic mode using mobile phase consisting of the mixture of 10mM Ammonium acetate pH adjusted to 4.5 and acetonitrile (70:30 v/v) with a flow rate of about 1.0 mL/min at ambient temperature. An ultra-violet detection of sulfasalazine and the internal standard was carried out at 362 nm. Both sulfasalazine and internal standard (IS, 4-hydroxy benzoate) were extracted from plasma matrices with high efficiency using a simple protein precipitation method. The method was found to be highly selective with no carryover effects. Linearity of sulfasalazine was found with the range of 2.5-100 μg/mL with the value of r2 > 0.995 a correlation coefficient. At all three quality control levels, developed bioanalytical method was found as repeatable and reproducible as well. The average recoveries of sulfasalazine from plasma were in the range of 95.59-97.16%. The bioanalytical samples showed good and acceptable stability of sulfasalazine solution at different storage, packaging and handling conditions. Hence, in conclusion, the validated and developed HPLC-UV method could be effectively utilized for determination of sulfasalazine in pharmacokinetic studies involving novel formulations.
- 26 June 2021
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 33 (7) , 1692-1698
Open AccessBioanalytical Method Development and Validation for Determination of Sulfasalazine in Rabbit Plasma by HPLC-UV
In present study, an advanced, simple and a rapid reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the quantitative determination of sulfasalazine in rabbit plasma. Sulfasalazine was separated using Chromatopak C-18 basic peerless (250 mm × 4.6 mm, 5μ) column in an isocratic mode using mobile phase consisting of the mixture of 10mM Ammonium acetate pH adjusted to 4.5 and acetonitrile (70:30 v/v) with a flow rate of about 1.0 mL/min at ambient temperature. An ultra-violet detection of sulfasalazine and the internal standard was carried out at 362 nm. Both sulfasalazine and internal standard (IS, 4-hydroxy benzoate) were extracted from plasma matrices with high efficiency using a simple protein precipitation method. The method was found to be highly selective with no carryover effects. Linearity of sulfasalazine was found with the range of 2.5-100 μg/mL with the value of r2 > 0.995 a correlation coefficient. At all three quality control levels, developed bioanalytical method was found as repeatable and reproducible as well. The average recoveries of sulfasalazine from plasma were in the range of 95.59-97.16%. The bioanalytical samples showed good and acceptable stability of sulfasalazine solution at different storage, packaging and handling conditions. Hence, in conclusion, the validated and developed HPLC-UV method could be effectively utilized for determination of sulfasalazine in pharmacokinetic studies involving novel formulations.
- Open Access
- 8 June 2020
- Published by Bentham Science Publishers Ltd. in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
- Vol. 19 (2) , 103-112
Anti-inflammatory Effect of Woodfordia fructicosa Leaves Ethanolic Extract on Adjuvant and Carragenan Treated Rats
Background: Woodfordia fructicosa is used traditionally for the treatment of inflammation associated with arthritis. Methods: In the present study, the anti-inflammatory activity of W. fructicosa (WFE) leaves ethanolic extract was assessed in Sprague Dawley rats by giving 200 mg/kg dose orally. Inflammation was studied by using carrageenan induced paw edema, Freund’s adjuvant (FA) and monosodium iodo acetate (MIA) induced arthritis as animal models. Serum tumor necrosis factor-alpha (TNF-α) was estimated in blood sample of animals treated with FA. The one way ANOVA followed by Bonferroni’s test was used for statistical analysis. Results: WFE significantly decreased (P<0.05, P<0.001) paw thickness in carrageenan induced paw edema and FA induced arthritis. The significant decrease in knee diameter (P<0.001) in MIA induced arthritis as well as inhibitory effect (P<0.001) on elevated TNF- α was observed. Conclusion: These results showed that the WFEexerted an inhibitory effect on TNF-α and carrageenan paw edema which may justify its traditional use in inflammatory conditions. Thus, the study shows that leaves of W. fruticose afford anti-inflammatory activity by preventing the inflammation in different animal models.
- 8 June 2020
- Published by Bentham Science Publishers Ltd. in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
- Vol. 19 (2) , 103-112
Open AccessAnti-inflammatory Effect of Woodfordia fructicosa Leaves Ethanolic Extract on Adjuvant and Carragenan Treated Rats
Background: Woodfordia fructicosa is used traditionally for the treatment of inflammation associated with arthritis. Methods: In the present study, the anti-inflammatory activity of W. fructicosa (WFE) leaves ethanolic extract was assessed in Sprague Dawley rats by giving 200 mg/kg dose orally. Inflammation was studied by using carrageenan induced paw edema, Freund’s adjuvant (FA) and monosodium iodo acetate (MIA) induced arthritis as animal models. Serum tumor necrosis factor-alpha (TNF-α) was estimated in blood sample of animals treated with FA. The one way ANOVA followed by Bonferroni’s test was used for statistical analysis. Results: WFE significantly decreased (P<0.05, P<0.001) paw thickness in carrageenan induced paw edema and FA induced arthritis. The significant decrease in knee diameter (P<0.001) in MIA induced arthritis as well as inhibitory effect (P<0.001) on elevated TNF- α was observed. Conclusion: These results showed that the WFEexerted an inhibitory effect on TNF-α and carrageenan paw edema which may justify its traditional use in inflammatory conditions. Thus, the study shows that leaves of W. fruticose afford anti-inflammatory activity by preventing the inflammation in different animal models.
- Open Access
- 1 December 2018
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 108, 1477-1494
Biomedical applications of microemulsion through dermal and transdermal route
- 1 December 2018
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 108, 1477-1494
Open AccessBiomedical applications of microemulsion through dermal and transdermal route